Back to search

Article

Translational Potential and Pharmacokinetic Challenges of Procyanidin C1 as a Next-Generation Senotherapeutic Agent

2026-02-19

Abstract excerpt

Procyanidin C1 (PCC1), a B-type procyanidin trimer derived from natural sources, has recently garnered significant attention in preclinical models due to its potential to specifically induce apoptosis in senescent cells (senolytic activity) and extend healthspan. However, existing data reveal a pronounced pharmacological paradox: the in vitro induction of apoptosis in senescent cells typically requires high microm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
de1ffd2c-a6e7-5c49-ab21-2f8ae6a982a5
DOI
10.20944/preprints202602.1086.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Translational Potential and Pharmacokinetic Challenges of Procyanidin C1 as a Next-Generation Senotherapeutic AgentDOI 10.20944/preprints202602.1086.v1
Select a neighboring publication to make it the new centre.